Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE2144.7052.7 (+2.52 %)
PREV CLOSE () 2092.00
OPEN PRICE () 2090.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 134400
TODAY'S LOW / HIGH ()2079.00 2144.70
52 WK LOW / HIGH ()1900.3 2530
NSE2083.00-15.1 (-0.72 %)
PREV CLOSE() 2098.10
OPEN PRICE () 2088.10
BID PRICE (QTY) 2083.00 (51627)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1194290
TODAY'S LOW / HIGH() 2075.00 2114.70
52 WK LOW / HIGH ()1900 2529.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
05Sep Lupin gets USFDA’s nod for Modafinil T
Lupin has received approval from the United States Food and Drug Adminis..
17Aug Lupin gets USFDA’s final nod for Pitol
Lupin has received the final approval from the United States Food and Dr..
17Aug Lupin rises on getting USFDA’s final n
Lupin is currently trading at Rs. 2260.35, up by 25.35 points or 1.13% f..
10Aug Lupin gets USFDA’s nod for Sodium Zirc
Lupin has received approval from the U.S. Food and Drug Administration (..
07Aug Lupin reports 16% rise in Q1 consolida
Lupin has reported its results for the first quarter ended June 30, 2026..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit2714663665.6
Gross Profit 36100.6 76942.5
Operating Profit 38356.381163.3
Net Sales 71719195126.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27273.30 (5.26%)
M.Cap ( in Cr)
57953.86
Neuland Laboratories (BSE)
 22875.70 (0.97%)
M.Cap ( in Cr)
29349.27
Alkem Laboratories (BSE)
 5501.60 (3.03%)
M.Cap ( in Cr)
65779.88
Caplin Point Labs. (BSE)
 2747.85 (5.87%)
M.Cap ( in Cr)
20886.87
Acutaas Chemicals (BSE)
 3438.15 (3.70%)
M.Cap ( in Cr)
28148.52
Shareholding Pattern
PROMOTERS 46.85%
MUTUAL FUNDS/UTI 14.84%
FI/BANKS/INSURANCE 6.98%
NON-INSTITUTION 6.08%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74294.96-19.63 (-0.03%)
NIFTY23346.4075.80 (0.33%)
Dow Jones 51778.00316.10 (0.61%)
Nasdaq 26418.30439.87 (1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI